Developmental and stress-related changes of neurotrophic factor gene expression in an animal model of schizophrenia

Molecular Psychiatry

Volumn 6, Issue 3, 2001, Pages 285-292

  Molteni, R ^a   Lipska, B K ^c   Weinberger, D R ^c   Racagni, G ^a,b   Riva, M A ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Brain derived neurotrophic factor; Brain plasticity; Fibroblast growth factor 2; Hippocampus; Ibotenic acid; Stress

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; FIBROBLAST GROWTH FACTOR 2; IBOTENIC ACID; MESSENGER RNA; NEUROTROPHIC FACTOR;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEVELOPMENT; FRONTAL CORTEX; GENE EXPRESSION; HIPPOCAMPUS; NERVE CELL PLASTICITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; STRESS;

ANIMALS; BRAIN CHEMISTRY; BRAIN-DERIVED NEUROTROPHIC FACTOR; DENERVATION; DISEASE MODELS, ANIMAL; EXCITATORY AMINO ACID AGONISTS; FEMALE; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION; GYRUS CINGULI; HIPPOCAMPUS; IBOTENIC ACID; NEURONAL PLASTICITY; PREFRONTAL CORTEX; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; RESTRAINT, PHYSICAL; RNA, MESSENGER; SCHIZOPHRENIA; STRESS, PSYCHOLOGICAL;

EID: 0035059960     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000865     Document Type: Article

References (64)

1. Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17
2. Size, shape and orientation of neurons in the left and right hippocampus: Investigation of normal asymmetry in neuronal density and alternations in schizophrenia
3. The hippocampus in schizophrenia: Lateralized increase in neuronal density and altered cytoarchitectural asymmetry
4. Schizophrenia as a chronic active brain process: A study of progressive brain structural change subsequent to the onset of schizophrenia
5. Postmortem studies of the hippocampal formation in schizophrenia
6. From neuropathology to neurodevelopment
7. Cortical maldevelopment, anti-psychotic drugs and schizophrenia: A search for common ground
8. Schizophrenia: A disorder of neurodevelopment?
9. Schizophrenia as a developmental disorder of the cerebral cortex
10. Neurotrophic factors and the maldevelopmental hypothesis of schizophrenic psychoses
11. Trophic factors and neuronal survival
12. Neurotrophins and neuronal plasticity
13. Trophic regulation of synaptic plasticity
14. Neurotrophins and synaptic plasticity
15. Fibroblast growth factors: Activities and significance of non-neurotrophin neurotrophic growth factors
16. Developmental expression of basic fibroblast growth factor gene in rat brain
17. NT-3, BDNF and NGF in the developing rat nervous system: Parallel as well as reciprocal patterns of expression
18. Impaired cerebral cortex development and blood pressure regulation in FGF-2-deficient mice
19. Changes in cerebral cortex size are governed by fibroblast growth factor during embryogenesis
20. Identification of cells in rat brain and peripheral tissues expressing mRNAs for members of the nerve growth factor family
21. Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain
22. Requirement for BDNF in activity-dependent survival of cortical neurons
23. Brain-derived neurotrophic factor promotes the survival and the sprouting of serotoninergic axons in rat brain
24. Increased levels of messenger RNAs for neurotrophic factors in the brain during kindling epileptogenesis
25. Neurotrophins and brain insults
26. Different patterns of induction of FGF-2, FGF-1 and BDNF mRNA during kindling epileptogenesis in the rat
27. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in hippocampus
28. Stress increased brain-derived neurotrophic factor messenger ribonucleic acid in the hypothalamus and pituitary
29. Interplay between glutamate and -aminobutyric acid transmitter systems in the physiological regulation of brain-derived neurotrophic factor and nerve growth factor synthesis in hippocampal neurons
30. GABAergic stimulation switches from enhancing to repressing BDNF expressing in rat hippocampal neurons during maturation in vitro
31. Biological roles of fibroblast growth factor-2
32. Basic fibroblast growth factor mRNA increases in specific brain regions following convulsive seizures
33. Short- and long-term induction of basic fibroblast growth factor gene expression in rat central nervous system following kainate injection
34. Regulation of basic fibroblast growth factor and nerve growth factor mRNA by β-adrenergic receptor activation and adrenal steroids in rat central nervous system
35. Opposite regulation of basic FGF and NGF gene expression in rat cortical astrocytes following dexamethasone treatment
36. Cyclic AMP-dependent regulation of fibroblast growth factor-2 messenger RNA levels in rat cortical astrocytes: Comparison with fibroblast growth factor-1 and ciliary neurotrophic factor
37. Physical exercise induces FGF-2 and its mRNA in the hippocampus
38. Spatial learning and physical activity contribute to the induction of fibroblast growth factor: Neural substrates for increased cognition associated with exercise
39. Basic fibroblast growth factor prevents death of lesioned cholinergic neurons in vivo
40. Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice
41. Fibroblast growth factor-2 protects entorhinal layer II glutamatergic neurons from axotomy-induced death
42. NGF and bFGF protect rat hippocampal and human cortical neurons against hypoglycemic damage by stabilizing calcium homeostasis
43. Blockade of basic fibroblast growth factor retards recovery from motor cortex injury in rats
44. Postpubertal emergence of hyperresponsiveness to stress and to amphetamine alter neonatal excitotoxic hippocampal damage: A potential animal model of schizophrenia
45. Delayed effects of neonatal hippocampal damage on haloperidol-induced catalepsy and apomorphine-induced stereotypic behaviors in the rat
46. Neonatal excitotoxic hippocampal damage in rats causes postpubertal changes in prepulse inhibition of startle and its disruption by apomorphine
47. Genetic variation in vulnerability to the behavioral effects of neonatal hippocampal damage in rats
48. Neonatal lesion of rat ventral hippocampus result in hyperlocomotion and deficits in social behavior in adulthood
49. Subchronic treatment with haloperidol and clozapine in rats with neonatal excitotoxic hippocampal damage
50. Cognitive effects of neonatal hippocampal lesion in a rat model of schizophrenia
51. Neurobiological investigations in cingulate cortex of schizophrenic brain
52. Single step method of RNA isolation by guanidium thiocyanate-choroform extraction
53. Postpubertal emergence of prefrontal neuronal deficits and alterated dopaminergic behaviors in rats with neonatal hippocampal lesions
54. Effects of neonatal hippocampal lesions on prefrontal cortical pyramidal cell responses to VTA stimulation
55. Stress reduction in the social environment of schizophrenic patients
56. Stressful life events and schizophrenia: A review of the research
57. Treatment of schizophrenia
58. Novelty-induced increase in dopamine release in the rat prefrontal cortex in vivo: Inhibition by diazepam
59. Attenuated extracellular dopamine levels after stress and amphetamine in the nucleus accumbens of rats with neonatal ventral hippocampal damage
60. Temporal dynamics of glutamate efflux in the prefrontal cortex and in the hippocampus following repeated stress: Effects of pretreatment with saline or diazepam
61. Glutamate receptor dysfunction and schizophrenia
62. The neuropsychopharmacology of phencyclidine: From NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia
63. Glutamatergic regulation of basal and stimulus-activated dopamine release in the prefrontal cortex